Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Au@PDA-125I as the Embolism Beads for Radiosensitization of liver cancer

Xiao Li and Changjing Zuo
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1093;
Xiao Li
1Changhai Hospital Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changjing Zuo
1Changhai Hospital Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1093

Objectives: To prepare a kind of embolism bead with the functions of radiosensitization and intra-irradiation for therapy and real-time SPECT/CT monitoring of therapeutic time window, all in one.

Methods: Au nanoparticles (3.8 ± 0.6 nm) were assembled to sub-micron Au particles (186.3 ± 20.4 nm) and then covered with poly-dopamine (PDA) as embolism beads (198.8 ± 23.2 nm) with the ability of radiosensitization. Radioactive iodine-125 was labeled to Au@PDA to introduce the function of intra-irradiation. Finally, the therapeutic effect of Au@PDA-125I were testified in MHCC97H hepatoma cells and the mice models bearing liver tumor. Results: For the therapeutic effects, Au@PDA-125I obviously sensitized the radiation to MHCC97H hepatoma cells and tumor-bearing mice. At the cellular level, after being treated with a relatively low dose (5 Gy) of γ-ray, Au-sensitized radiotherapy (RT) lead to an immediate increase of reactive oxygen species, accompanying with an increase of cell apoptosis. Resulting from the adding of I-125, self-healing of RT-lead double-strand breakage of DNA was suppressed, inducing the continuous increase of cell apoptosis after the RT treatment. Likewise, with three cycles of 5 Gy treatments, the sensitized RT lead to a valid control of tumor volume growth, but had no harm or radioactive residual on/in the radio-sensitive organs, including the thyroid, heart, lung, liver and spleen. Additionally, the photon emission from I-125 makes the beads suitable for SPECT imaging, and the absorption of X-ray makes the beads CT-detectable. Conclusion: As a multi-functional embolism beads, Au@PDA-125I can obviously decrease the required radiation dose of RT, and provide a real-time SPECT/CT monitoring of the therapeutic time window. Figure 1. Biodistribution of intratumorally injected Na125I solution (left) and Au@PDA-125I suspension (right) characterized via planer imaging and CT; and the metabolism curve of injection point (G), thyroid (H) and whole body (I). Figure 2. Change of tumor volume and body weight after being treated with radiotherapy.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Au@PDA-125I as the Embolism Beads for Radiosensitization of liver cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Au@PDA-125I as the Embolism Beads for Radiosensitization of liver cancer
Xiao Li, Changjing Zuo
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1093;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Au@PDA-125I as the Embolism Beads for Radiosensitization of liver cancer
Xiao Li, Changjing Zuo
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1093;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Oncology Posters

  • Targeted molecular imaging of c-Met in NSCLC using 68Ga-labeled binding peptide
  • A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
  • A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator.
Show more Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire